Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TERF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LTN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP11B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLINT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101927365 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
AK6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALG10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNORA3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C11orf84 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EBAG9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LYSMD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MFN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRIX1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM103A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KAT6A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMBR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNCRIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PALM2-AKAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DHRS4-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on